Rising Pharmaceuticals

Vioquest Pharmaceuticals Inc. is a biotechnology company based in Monmouth Junction, NJ, focusing on the development of innovative therapeutic solutions for autoimmune diseases. With a strong emphasis on research and preclinical development, the company is advancing its pipeline of drug candidates, including PV-3212, aimed at treating multiple sclerosis and other autoimmune conditions. The company is dedicated to exploring MHC II inhibition and developing inhibitors targeting diseases such as Goodpasture's syndrome and Parkinson's. Vioquest Pharmaceuticals also provides drug discovery services supported by expert medicinal chemistry and therapeutic expertise to facilitate client-driven projects. Generated from the website

Halo Pharmaceutical Inc, located in Whippany, NJ, specializes in formulation development and commercial manufacturing of complex therapeutics, offering a comprehensive range of dosage forms including solids, liquids, semi-solids, and specialty dosage types. As part of the Noramco Group, Halo Pharma leverages its state-of-the-art facilities and expertise to support pharmaceutical innovators and generics in taking their products from concept to commercialization. With a robust portfolio that includes nearly 120 active product development projects and a noteworthy record of regulatory approvals, Halo Pharma effectively meets the needs of its diverse clientele. The company's commitment to safety, quality, and collaboration positions it as a trusted partner for businesses seeking efficient drug product development and manufacturing solutions. Generated from the website